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Abstract
The DNA polymerase gamma (Polg) is a nuclear-encoded enzyme involved in DNA replication in animal mitochondria.
In humans, mutations in the POLG gene underlie a set of mitochondrial diseases characterized by mitochondrial DNA
(mtDNA) depletion or deletion and multiorgan defects, named POLG disorders, for which an effective therapy is still
needed. By applying antisense strategies, ENU- and CRISPR/Cas9-based mutagenesis, we have generated embryonic,
larval-lethal and adult-viable zebrafish Polg models. Morphological and functional characterizations detected a set of
phenotypes remarkably associated to POLG disorders, including cardiac, skeletal muscle, hepatic and gonadal defects,
as well as mitochondrial dysfunctions and, notably, a perturbed mitochondria-to-nucleus retrograde signaling (CREB
and Hypoxia pathways). Next, taking advantage of preliminary evidence on the candidate molecule Clofilium tosylate
(CLO), we tested CLO toxicity and then its efficacy in our zebrafish lines. Interestingly, at well tolerated doses, the CLO
drug could successfully rescue mtDNA and Complex I respiratory activity to normal levels, even in mutant phenotypes
worsened by treatment with Ethidium Bromide. In addition, the CLO drug could efficiently restore cardio-skeletal
parameters and mitochondrial mass back to normal values. Altogether, these evidences point to zebrafish as a
valuable vertebrate organism to faithfully phenocopy multiple defects detected in POLG patients. Moreover, this
model represents an excellent platform to screen, at the whole-animal level, candidate molecules with therapeutic
effects in POLG disorders.
Introduction
In vertebrates, from fish to humans, the mitochondrial
DNA (mtDNA) is replicated by the DNA polymerase
gamma (Polg), encoded by the nuclear genome. Mutations
in the human POLG gene cause a series of mitochondrial
diseases with Mendelian inheritance, collectively named
POLG-related disorders, characterized by mtDNA deple-
tion (MDD) or accumulation of multiple deletions. These
disorders mainly include Alpers–Huttenlocher syndrome
(OMIM 203700), mitochondrial neurogastrointestinal
encephalopathy syndrome (MNGIE type) (OMIM 613662),
mitochondrial recessive ataxia syndrome (SANDO, SCAE)
(OMIM 607459), autosomal recessive progressive external
ophthalmoplegia (arPEO) (OMIM 258450) and autosomal
dominant progressive external ophthalmoplegia (adPEO)
(OMIM 157640). To date, about 300 pathogenic mutations
have been reported in the Human DNA Polymerase
Gamma Mutation Database (https://tools.niehs.nih.gov//
polg/). The mutations are associated with a spectrum of
clinical presentations, ranging from infantile-onset epi-
lepsies, liver failure, polyneuropathy, ataxia, dilated/hyper-
trophic cardiomyopathy, male infertility and premature
menopause, to late-onset ophthalmoplegia and muscle
© The Author(s) 2021
OpenAccessThis article is licensedunder aCreativeCommonsAttribution 4.0 International License,whichpermits use, sharing, adaptation, distribution and reproduction
in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if
changesweremade. The images or other third partymaterial in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to thematerial. If
material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Correspondence: Tiziana Lodi (tiziana.lodi@unipr.it) or Enrico Baruffini (enrico.
baruffini@unipr.it) or Francesco Argenton (francesco.argenton@unipd.it)
1Department of Biology, University of Padova, Padova 35131, Italy
2Department of Biomedical Sciences, University of Padova, Padova 35131, Italy
Full list of author information is available at the end of the article
Edited by E. Baehrecke


































weakness. To a limited extent, clinical phenotypes correlate
with the mtDNA genotype.
It must be considered that approximately 1% of the
population is carrier of a POLG mutation, indicating that
the potential frequency of POLG-related disorders is
about 1/10,000; in fact, it has been estimated that 10% of
adult mitochondrial diseases and 10–25% of PEO are
caused by mutations in POLG, and that the present
underestimation of the reported cases will be corrected
due to amelioration and precocity of the diagnosis1.
Ample information linked to POLG mutations has been
obtained from studies on the orthologous gene MIP1 in
the yeast Saccharomyces cerevisiae. This species is a very
suitable model organism for the study of mitochondrial
diseases, since it can survive and grow with MDD or large
deletions. Mutant cells produce small colonies, called
“petite”; the frequency of petite mutant onset is a direct
index of mtDNA instability. Moreover, the yeast has been
a fundamental organism for providing the first evidence
that loss of mtDNA can trigger distinct changes in nuclear
gene expression, in a molecular cross-talk known as
“mitochondria-to-nucleus retrograde signalling”2. Since
then, several mitochondria-to-nucleus communications
have been identified and characterized, among which Hif
(Hypoxia-Inducible Factor) and CREB (cAMP response
element-binding protein) signalling pathways, both highly
relevant in physiological metabolism and human disease3.
For all these reasons, the yeast plays an important role as a
model organism for the study of mitochondrial dysfunc-
tion and the validation of pathological mutations in
POLG4.
As far as concerns the animal models for POLG disease,
the roundworm Caenorhabditis elegans, mutated in the
corresponding polg-1 gene, has proved to be a good sys-
tem to study Polg deficiency and MDD5. Conversely,
mouse Polg mutants produced so far loose viability in
embryogenesis; a knockin transgenic line shows pre-
mature aging (“mutator mouse”), while mouse lines with
heart- or brain-specific mutations do not fully recapitulate
the entire spectrum of human disease phenotypes1.
In the last years, a zebrafish (Danio rerio) polg mutant
has been described by Rahn et al.6, developing severe
MDD, but dying at juvenile stage (4 weeks post-fertiliza-
tion), thus hindering further observations at adult stages.
A neutrophil-specific zebrafish polg knockout is also
available7, limiting, however, the analysis of polg function
only in this cell type.
To date, there are no evidence-based therapies for
POLG-related disorders, and no randomized controlled
clinical trials have been performed. The main treatment is
based on symptomatic therapy and supportive care1.
Thus, the identification of drugs, effective in the rescue of
MDD, is urgently needed.
While performing a large-scale drug screen in yeast and
worm Polg models, members of our collaboration group
succeeded in identifying a compound, Clofilium tosylate
(CLO), able to rescue the mutant phenotypes and, when
tested in fibroblasts from human POLG patients, effective
in increasing mtDNA levels8. As shown in the present
study, these preliminary results prompted us to test the
CLO efficacy at the whole vertebrate animal level, upon
generation of zebrafish-based models for POLG disorders.
In particular, the zebrafish line polgsa9574, bearing a
hypomorphic nonlethal point mutation in the polg gene,
could allow the long-term analysis of Polg-related phe-
notypes and the evaluation of CLO therapeutic effects at
both larval and adult stages.
Material and methods
Maintenance and handling of zebrafish lines
All experiments were performed in accordance with the
Italian and European Legislations (Directive 2010/63/
EU)9 and with permission for animal experimentation
from the Ethics Committee of the University of Padua and
the Italian Ministry of Health (Authorization number
407/2015-PR). Danio rerio (zebrafish) were maintained in
a temperature-controlled (28.5 °C) environment in a 12:12
light-dark (LD) cycle and fed as described by Kimmel and
colleagues9,10. For anaesthesia or euthanasia of zebrafish
embryos and larvae, tricaine (MS222; E10521,
Sigma–Aldrich) was added to the fish water at 0.16 mg/
mL or 0.3 mg/mL, respectively. Wild-type (wt) lines used
in this work included Tuebingen, Giotto and Umbria
strains11. For in vivo studies, the following transgenic lines
were used: liver-expressed Tg(lfabf:dsRed;elaA:EGFP)gz15
12; mitochondria-expressed Tg(Hsa.Cox8a:MLS-EGF-
P)ia301 13; myocardium-expressed Tg(tg:EGFP,myl7:EGF-
P)ia300 14; CREB signalling reporter Tg(6xCRE:EGFP)14;
Hif-Hypoxia signalling reporter Tg(4xHRE-TATA:
EGFP)ia21 15.
Morpholino-mediated polg knockdown
For polg gene knockdown, antisense morpholino (MO)
oligomers were designed and synthesized by GeneTools,
targeting the ATG region and the exon4–intron4
boundary of the immature transcript (Supplementary
Table 1). MOs were diluted to 2 μg/μL in 1x Danieau
buffer (58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO4,
0.6 mM Ca(NO3)2, 5 mM Hepes, pH 7.6) plus 1% phenol
red. For microinjection experiments, 1-cell stage embryos
were microinjected with 5 nL of solution. MO-injected
embryos (morphants) were raised in fish water with
0.003% PTU (P7629, Sigma) to prevent pigmentation, and
analysed within 3 days post-fertilization (dpf). Analysis of
MO effects on targeted transcripts (decrease and/or size
alteration) was performed by quantitative RT-PCR from
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RNA of 2 and 3 dpf morphants (primers listed in Sup-
plementary Table 1), followed by agarose gel electro-
phoresis and signal quantification using the
“Measurements” tool of the Volocity 6.0 software (Perkin
Elmer).
Whole-mount in situ hybridization (WISH)
Analysis of embryonic cardiac chambers was performed
by WISH using standard protocols16 and the following
probes: myh6 (myosin, heavy chain 6, cardiac muscle,
alpha) (ZDB-GENE-031112-1) for the atrium, and myh7
(myosin heavy chain 7) (ZDB-GENE-991123-5) for the
ventricle.
Generation and genotyping of zebrafish polg mutant lines
The zebrafish mutant line polgia302, bearing a 16-
nucleotide deletion in the polg gene, was generated by
CRISPR/Cas9-mediated genome editing. A single guide
RNA (sgRNA) was designed using the CHOPCHOP
software (https://chopchop.rc.fas.harvard.edu), to specifi-
cally target an optimal CRISPR sequence on exon 2 of
polg gene (XM_001921095). The chosen sgRNA (see
Supplementary. Table 1) was generated according to
Gagnon et al.17 and transcribed in vitro using the
MEGAshortscript T7 kit (AM1354, Life Technologies).
One-cell stage embryos were injected with 2 nL of a
solution containing 280 ng/μL of Cas9 protein (M0646,
New England Biolabs) and 68 ng/μL of sgRNA; phenol red
was used as injection marker. F0 injected embryos were
raised to adulthood and screened, by F1 genotyping, for
germline transmission of the mutation. Heterozygous
mutants, harbouring the mutation of choice, were out-
crossed 4 times and then incrossed to obtain homozygous
mutants (F5 generation). Screening primers for hetero-
zygous and homozygous fish (Supplementary Table 1),
were designed to amplify a 151-bp region across the polg
sgRNA target region. PCR products were resolved with
ethidium bromide-stained 3% agarose low EEO gel
(BP160-500, Fisher BioReagents) to identify polg+/+,
polg+/ia302 and polgia302/ia302 samples.
Polgsa9574/sa9574 point mutants (fish line ZDB-ALT-
130411-5185) were identified by HRMA or sequencing of
a 108-bp fragment which includes the polgsa9574 point
mutation, obtained by genomic DNA PCR amplification
(primers in Supplementary Table 1). Genomic DNA was
extracted using the HotSHOT protocol17 from single
larvae, euthanized with a lethal dose of tricaine, or from
fin clips. In the latter case, adult fish were anesthetized
with tricaine, and biopsies from the caudal fin were
removed using a sharp blade.
Birefringence assay
Muscle birefringence, linked to myofibril organization,
was analysed by placing anesthetized embryos, mounted
in 2% methyl cellulose, on a glass polarizing filter and
covering with a second polarizing filter in a Leica M165FC
microscope. Embryos were photographed in bright field
with a DFC7000T digital camera. The top filter was
twisted until it was possible to see the light refracting
through the striated muscle. Pixel intensity in the trunk
region was measured with ImageJ software. Values were
normalized for samples area because of the slight differ-
ences in the size between mutants and wt in analysed
stages. Three independent clutches of 10 larvae per gen-
otype and treatment were analysed for their muscle
birefringence.
Survival analysis
We crossed polgsa9574/sa9574 with polgsa9574/sa9574 and wt
with wt, respectively, so we had pools of homozygous
mutants and wt controls that we raised in different tanks
under the same conditions (water, light, food). Survival
analysis was carried out by counting the alive individuals
once per week, from 3 dpf until 3 months of age.
Histological analysis
polgsa9574/sa9574 and wt zebrafish were fixed for 24 h in
Bouin’s solution at room temperature. The samples were
dehydrated through graded series of ethanol, infiltrated
with xylene and embedded in Paraplast plus (39602004,
Leica). The samples were serially cut into 7–8-μm sec-
tions on a LKB microtome. After rehydration, the sections
were stained with haematoxylin and eosin and mounted
with Eukitt (09-00100, Bio Optica) for microscopic
examination.
Liver analysis
We measured the volume and the integrated density
(IntDen) of the fluorescent livers belonging to liver-
specific transgenic larvae Tg(lfabf:dsRed;elaA:EGFP)gz15 at
8 and 16 dpf. Measures were done using ImageJ proces-
sing imaging software, and data were analysed and
represented by GraphPad.
Transmission electron microscopy (TEM) analysis
Larvae were anaesthetized and fixed overnight in 2%
PFA, 2.5% glutaraldehyde in 0.1M Na cacodylate pH 7.4,
rinsed in 0.1M Na cacodylate buffer, and then included in
Epo812 resin. Subsequent TEM steps were performed as
described in Giuliodori et al.14. Images were acquired with
Philips TEM CM 12.
Mitochondrial DNA quantification
DNA samples, extracted from 10 pooled larvae at 3, 6 and
10 dpf, were prepared as described by Rahn et al.6 and
quantified by PicoGreen assay (Invitrogen) using the Infi-
nite 200 PRO plate reader (Tecan). Then, 8.5 ng of each
sample were used in a qPCR reaction and run in triplicate,
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using 5× HOT FIREPol® EvaGreen® qPCR Supermix
(Solis Biodyne). Mitochondrial DNA copy number was
determined by the RT-qPCR standard curve method using
mt-nd1 as the mitochondrial gene target and the polg gene
as a reference for nuclear DNA, following the protocol
developed by Artuso and colleagues18.
RNA extraction and RT-qPCR
Total mRNA was extracted from 30 larvae using Trizol
(Invitrogen) and reverse-transcribed using SuperScript®
III First-Strand (Thermo Fisher Scientific). Quantitative
PCR (qPCR) was performed in triplicated using a Rotor-
gene Q (Qiagen) and 5× HOT FIREPol® EvaGreen®
qPCR Mix Plus (Solis BioDyne), following the manu-
facturers’ protocols. The cycling parameters were 95 °C
for 14min, followed by 45 cycles at 95 °C for 15 s, 59 °C
for 20 s and 72 °C for 20 s. Threshold cycles (Ct) and
dissociation curves were generated automatically by
Rotor-Gene Q series software. Sample Ct values were
normalized with Ct values from zebrafish actb2 and rplp0,
used as control genes. Primer sequences are listed in
Supplementary Table 1. All primers were designed using
the software Primer319.
Locomotion assay
Behavioural experiments were performed using the
DanioVision tracking system (Noldus Information Tech-
nology, Wageningen, The Netherlands). Larvae at 6 and
15 dpf were placed in 48-well plates, with one larva per
well in 500 μL of fish water. After 20 min of acclimation,
movements of larvae were recorded repeating three cycles
of 10 min of light and 10 min of dark, as previously
described in MacPhail et al.20.
Ejaculate collection
Fish were isolated for 2 days before stripping, to guarantee
the replenishment of sperm reserve. Males were anesthe-
tized in Tricaine 1X (0.16mg/mL), gently dried on a paper
towel and placed in a dampened sponge ventral side up,
with their genital papilla exposed. The ventral surface of the
fish was further dried to remove any excess water that could
prematurely activate the sperm. The fish abdomen was
gently pushed with soft plastic tweezers and the ejaculate
was collected from the genital papilla by means of a
Drummond microdispenser equipped with a 5 μL micro-
capillary tube. The whole ejaculate was diluted and pre-
served until analyses (within 1 hour) in 20 μL of zebrafish
sperm immobilizing solution (ZSI: 140mM NaCl, 10mM
KCl, 2mM CaCl2, 20mM HEPES, pH=8.5)
21. A total
number of 21 males, 8 belonging to polg+/+ and 13 to
polgsa9574/sa9574 were stripped. Three males belonging to the
polgsa9574/sa9574 line did not produce any ejaculate and, thus,
a value of zero was attributed to these males when analysing
sperm concentration.
Sperm concentration
Sperm counts were performed using an improved
Neubauer haemocytometer under ×400 magnification,
after properly diluting 2 μL of a subsample taken from the
whole ejaculate maintained in ZSI. The sample was gently
mixed with a micropipette before filling the chamber. The
average of five counts per sample was used to estimate
sperm concentration, considering dilution steps, and
expressed as number of spermatozoa/mL.
Sperm viability
Sperm viability was measured as the proportion of
alive sperm using a Live/Dead Sperm Viability Kit
(Molecular Probes). A membrane-permeable nucleic
acid stain (SYBR14) labelled live sperm in green, and a
membrane-impermeable stain (propidium iodide, PI)
labelled dead sperm in red. Two microlitre of sample
were diluted by the addition of 10 μL of ZSI, first stained
with the addition of 1.5 μL SYBR14, incubated for 5 min
at 36 °C and, then, stained with the addition of 1 μL of
PI, followed by other 5 min of incubation at 36 °C. Five
microlitre of stained sample were deposited on a slide,
gently covered with a coverslip, and examined under a
fluorescence microscope (Leica M165FC dissecting
microscope equipped with a DFC7000T camera, Leica
Microsystems) at ×400 magnification. The proportion of
live sperm was calculated for at least 100 spermatozoa
per slide, and the mean values of two slides were used
for the analyses (within sample repeatability= 0.87 ±
0.06 st. error, see ref. 22.
Sperm velocity
Sperm were activated by gently mixing with a Gilson
micropipette 1 μL of ejaculate preserved in ZSI with
10 μL of aged tap water. Three microliters of samples
were then quickly placed in separate wells on a 12-well
multitest slide (MP Biomedicals) and covered with a
18 × 18 mm coverslip. Both slide and coverslip were
previously coated with 1% polyvinyl alcohol
(Sigma–Aldrich), to avoid sperm sticking to the glass
slide21. Sperm velocity was measured using a CEROS
Sperm Tracker (Hamilton Thorne Research) in the first
10 seconds after activation. The measurement was
repeated on three subsamples per male, leading to a
repeatability of 0.68 ± 0.1422, and mean values were used
for statistical analyses. Mean velocity measurements
were based on 280 ± 169 (mean ± s.d.) sperm tracks per
male. Since sperm velocity parameters (VAP: average
path velocity, VSL: straight-line velocity, and VCL:
curvilinear velocity) were highly correlated (all Pearson
R > 0.88; all p < 0.001), only VAP was considered in the
following analyses. The measurement was repeated
twice per male, yielding a repeatability of 0.68 ± 0.1422,
and mean values were used for statistical analyses.
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Ethidium bromide and CLO treatments
Ethidium bromide treatment, to induce mtDNA
depletion, was performed according to Rahn and collea-
gues6. Exposure to CLO (Clofilium tosylate, C2365,
Sigma–Aldrich) was performed by incubating zebrafish
larvae for 7 days (from 5 dpf to 12 dpf) in fish water-
diluted drug, without methylene blue.
Measurement of oxygen consumption rate (OCR)
OCR was measured on zebrafish embryos at 96-h post-
fertilization (hpf) with a Seahorse XF24 extracellular flux
analyser. Embryos were placed into a XF24 microplate
well (1 embryo per well) and blocked with a capture
screen in the presence of 670 μL of fish water (0.5 mM
NaH2PO4, 0.5 mM NaHPO4, 3 mg/L instant ocean). The
basal respiration was measured for 68 minutes at 28.5 °C.
Respiratory rates are average ±SEM of at least 20 indivi-
dual embryos per condition.
Measurement of respiratory complex I activity
To measure the enzymatic activity of respiratory
Complex I tissues were homogenized in a buffer com-
posed of KH2PO4 at pH 7.4 in the presence of protease
and phosphatase inhibitors. Total lysates were then
quantified using a BCA Protein Assay Kit (Thermo-Sci-
entific). Tissue homogenates were incubated for
5 minutes at 37 °C in a buffer composed of KH2PO4 pH
7.4, alamethicin 4 μM, BSA 6mg/mL, sodium azide 1 mM,
Coenzyme Q1 13.5 μM. Reactions were performed at
37 °C and started after the addition of the substrate
NADH (60 μM). Complex I activity was measured fol-
lowing NADH oxidation at 340 nm (ε= 6.4 nM−1 cm−1)
and subtracting the rotenone (20 μM) sensible fraction.
Analysis of oxidative stress in zebrafish embryos
The MitoSOX indicator (M36008, Invitrogen, Thermo
Fisher Scientific), was diluted to 5mM in DMSO to make
a reagent stock solution, as described in Mugoni and
colleagues23. The stock solution was dissolved in HBSS
(Hanks’s Balanced Salt Solution), to prepare a 5 μM
working solution, and pre-warmed at 28.5 °C. MitoSOX
was then added to an equal volume of fresh water on
embryos and incubated at 28.5 °C in the dark for 25min.
Embryos were then rinsed three times in fresh fish water
medium before imaging. Oxidation of the MitoSOX
indicator by mitochondrial superoxide produces a red
fluorescence, acquirable by confocal microscopy
(absorption/emission at 510/580 nm).
Imaging
For live imaging, transgenic embryos and larvae were
anesthetized with Tricaine 1X (0.16 mg/mL), embedded
in 1% low-melting agarose, placed on a depression slide
and analysed with a Leica M165FC dissecting
microscope equipped with a DFC7000T camera (Leica
Microsystems) or using a Nikon Eclipse 90i upright
microscope in a confocal C2 system (Nikon Instru-
ments). Transgenic fluorescence of Tg(Hsa.Cox8a:MLS-
EGFP)ia301 in polg mutant background was visualized
under a Leica M165FC dissecting microscope and then
with Leica SP5 and SP8 confocal microscopes through
×63 immersion objectives. WISH-stained embryos and
larvae were mounted in 87% glycerol in phosphate-
buffered saline plus and observed under a Leica
M165FC microscope, equipped with a DFC7000T digital
camera or with Leica SP5 confocal microscope. Histo-
logical samples were photographed on a Leica DMR
using a DFC7000T digital camera.
Signal quantification and statistical analysis
Zebrafish experiments implied two-sided tests on con-
tinuous variables (anatomical dimensions, fluorescence
intensities, cell numbers), varying around a mean value
with a 15% standard deviation, and with at least a 30%
increase/decrease of the values in mutated/treated sam-
ples, compared to controls. With a 1:1 ratio between
controls and mutated/treated samples, alpha error= 0.05
and statistical power= 95%, the required size of the
sample population implied six controls and six mutated/
treated samples (N= 6 samples per condition; Sample
Size Calculator, ClinCalc.com). Individuals with gross
congenital malformations (usually around 5–10% in an
egg clutch) were excluded from the analysis. Samples
from multiple fish crosses were randomized among all
conditions, to prevent background-related differences.
Blinded documentations were performed to avoid
observer bias.
Zebrafish experiments were performed in triplicate on
at least ten individuals per condition, and at least six
samples were measured per condition (N= 6 per condi-
tion). For signal quantification, fluorescent dots were
counted with the “Measurements” option of the Volocity
6.0 software (Perkin Elmer) or by Fiji software as already
described24. After background subtraction, the integrated
density of the signal (sum of pixels in a fixed volume) was
normalized to control and indicated in the charts as
Relative Intensity (R.I.). Statistical analysis was performed
in GraphPad Prism 8.0. The Shapiro–Wilk normality test
was used to confirm the normality of the data. In case data
passed normality test (alpha= 0.05), then a parametric
test, such as unpaired t-test or ordinary one-way ANOVA
(in case of multiple comparisons) was used. In case the
data did not pass the normality test, a nonparametric test
was used (Mann-Whitney test or Kruskal–Wallis test for
multiple comparisons). To correct for multiple compar-
isons, either Tukey’s multiple comparisons test (for
ordinary one-way ANOVA) or Dunn’s multiple compar-
isons test (for Kruskal–Wallis test) was used.
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The tests of sperm concentration, viability and velocity
were performed using RStudio version 1.1.447. Data on
sperm concentration and velocity were log transformed;
data on sperm viability were arcsine transformed. Differ-
ences in sperm concentration, viability and velocity as an
effect of male line (polg+/+ vs. polgsa9574/sa9574) were
analysed by linear models (LMs). All LMs yielded nor-
mally distributed residuals (Shapiro–Wilk normality test.
Sperm concentration: W= 0.940, p= 0.219; viability:
W= 0.919; p= 0.125; velocity: W= 0.943, p= 0.360).
The values reported in the figures represent mean ±
SEM calculated from at least six measures per condition.
Significant differences from controls are indicated by
asterisks. Correspondence between asterisks and sig-
nificance levels is indicated in the figure legends.
Results
Knockdown of zebrafish polg affects embryonic growth,
mitochondrial morphology and cell signalling
To preliminarily establish the effects of a decreased
activity of the polg gene in zebrafish, we transiently tar-
geted the maturation of its transcript using splice-
blocking morpholino oligomers. This treatment elicited
the appearance of altered transcript forms and the halving
of polg mRNA levels (Fig. 1A, B, M). Morphant embryos,
examined within 3 dpf, displayed a reduced body size in
the absence of gross dysmorphology (Fig. 1G, I, J, O),
except for a peculiar enlargement of the cardiac atrium
(Fig. 1C, D, N), associated with increased heart rate
(shown later, in Fig. 6). Ultrastructural TEM analysis,
performed in the skeletal muscle of morphant embryos,
detected mitochondria frequently fused and with a swol-
len morphology (Fig. 1E, F).
Taking advantage of pathway reporter zebrafish lines,
we could assess in vivo, at the whole-animal level, if polg
deficiency affects metabolic signalling cascades relevant in
mitochondria-to-nucleus cross-talk, such as Hif-Hypoxia
and CREB pathways. We found that both Hif-Hypoxia
signalling, verified with two independent reporters (Fig.
1H, K, L, P) and CREB signalling (Supplementary Fig. 1A,
B, C) were upregulated in polg morphant embryos; a
patterning pathway such as Wnt, also considered in the
analysis, appeared unmodified at the same stages (Fig. 1K,
L, Q). Collectively, these data suggest that polg knock-
down, induced by antisense strategy, can affect embryonic
metabolism, leading to reduced embryonic growth,
mitochondrial dysmorphology and alteration of pathways
involved in mitochondria-nucleus retrograde signalling.
Genome editing of the polg gene; genotyping of polgia302
and polgsa9574 mutant lines
The zebrafish Polg protein contains 1206 amino acids
(aa) and is composed of three major domains: exonuclease
domain (230–421), linker region (421–741) and
polymerase domain (741–1167). Zebrafish Polg has the
same functional domains and a 69% overall identity (79%
similarity) to human POLG18.
In 2015 Rahn and colleagues generated a zebrafish
mutant for the polymerase domain of the polg gene,
characterized by a rapid and sustained mitochondrial
DNA depletion, altered energetics and growth, which
failed to survive to 4 weeks6.
To generate a new zebrafish model, completely devoid
of polymerase gamma activity, our group mutated the
zebrafish polg gene in the exonuclease domain, using the
CRISPR/Cas9 approach.
A heterozygous F1 offspring with a 16-nucleotide
deletion in exon 2 (allele polgia302) was selected and
used to obtain the F2 generation (Fig. 2A). All genotypes
could be easily distinguished by PCR amplification and
agarose gel analysis of DNA obtained by fin clips (Sup-
plementary Fig. 2A). The 16-nucleotide deletion resulted
in a frameshift mutation that leads to a 3-aa miscoded
protein sequence after aa 231, and a premature stop at aa
235. F2 individuals were sequenced to confirm that they
shared an identical mutation (Supplementary Fig. 2B).
In addition, we obtained from the European Zebrafish
Resource Centre (EZRC) a potentially hypomorphic
mutant called polgsa9574/sa9574, bearing a rather terminally
located C/T transition that leads to a nonsense mutation,
with the loss of the last 6 aa (Fig. 2A). Genotyping was
performed by PCR combined with high-resolution melt-
ing analysis (HRMA). This approach is rapid, sensitive,
and cost-effective, with low risk of contamination arte-
facts (Supplementary Fig. 2C). Sequencing of F2 indivi-
duals fully confirmed the presence of the expected sa9574
point mutation (Supplementary Fig. 2D).
The polgia302 and polgsa9574 mutant lines display different
survival rates
We next investigated the survival rate for all genotypes
in both mutant lines. Concerning the polgia302 line, the
observed genotypes in the progeny from two hetero-
zygous fish did not significantly differ from the expected
proportions (25% polg+/+, 50% polg+/ia302 and 25% pol-
gia302/ia302), when analysed at 5 dpf. However, this dis-
tribution was significantly different from the expected
ratios at 21 dpf (Fig. 2B). These data indicate that pol-
gia302/ia302 animals have normal survival at early larval
stages, but begin to die at later stages and, similarly to
what observed for polg mutants generated by Rahn and
colleagues6, homozygous mutants cannot reach adult-
hood. Since adult polgia302/ia302 are not viable, most of the
experiments shown in this paper were obtained from the
polgsa9574/sa9574 line.
Survival of the polgsa9574 line was determined by col-
lecting control and homozygous mutant embryos, and
growing them until 3 months. This analysis showed that
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polgsa9574/sa9574 animals have normal survival until 2 wpf
(weeks post-fertilization) but begin to die after that time.
The critical rearing period for all genotypes was found
between 10 and 25 dpf. Thereafter, the decline in the
survival rate levelled at around 45% in wt fish and 18% in
polgsa9574/sa9574 mutants (Fig. 2C). This decrease in early
life survival was statistically significant comparing polg+/+
with polgsa9574/sa9574.
Homozygous polgia302 and polgsa9574 mutants display a
reduced body size at larval and adult stages
We quantified the growth characteristics of wt, polgia302
and polgsa9574 animals during the first three months of
development. Figure 2D, E, from juvenile to adult stages
(15–16 to 90 dpf), highlights the reduced body development
of mutant individuals compared to wt. The body length
(measured from the snout to the base of the caudal fin) is a
quantifiable indicator of development in zebrafish. The
measurements were performed on wt, heterozygous and
homozygous fish for the mutation. Homozygous mutants
grew more slowly than wt and were significantly smaller than
control siblings from the juvenile stage onwards (Fig. 2D–G).
This reduced growth is maintained in polgsa9574/sa9574
mutants until fish adulthood (Fig. 2E, G).
Multiorgan defects and reproductive impairment in
polgsa9574 mutants
Survival during adulthood of the hypomorphic
polgsa9574 mutant line could allow us to evaluate polg
mRNA levels in a tissue-specific manner. This analysis
detected a general decrease of polg expression in all
considered tissues, especially in brain, eye and heart
(Supplementary Fig. 2E).
Cardiac histology on 4-month post-fertilization (mpf)
polgsa9574/sa9574mutants showed dilated heart and reduction
of the trabecular network and its thickness, compared to
controls (Fig. 3A). Gonadal histology was also performed,
detecting anomalies in both sexes. Wild-type females at 5
mpf presented normal ovaries, with follicles at all develop-
mental stages, ranging from primary to full growth stage (Fig.
3B). Histological analysis of age-matched polgsa9574/sa9574
females showed instead an increase of atretic oocytes and
subsequent debris, with interruption and fragmentation of
the vitelline envelope, suggesting alteration of follicle
maturation (Fig. 3B). As far as concerns male gonads, sper-
matozoa at all developmental stages were detected in both wt
and polgsa9574/sa9574 testes; however, mutant testes were
comparatively smaller and with a reduced amount of sperm
(Fig. 3C).
As we noted that polgsa9574 mutants had difficulties to
reproduce, we focused our attention on sperm quality.
Sperm concentration did not significantly differ between
polg+/+ and polgsa9574/sa9574 males, although a trend to a
lower sperm concentration in polgsa9574/sa9574 was
observed (p= 0.079) (Fig. 3D). Moreover, there was no
difference in sperm velocity between polg+/+ and
polgsa9574/sa9574 ejaculates (LM: estimate= 0.070, st.err.=
0.070, t-value= 1.013, p= 0.327, d.f.= 15) (Fig. 3E).
However, ejaculates from polgsa9574/sa9574 males contained
a significantly lower amount of alive sperm compared to
controls, as revealed by SYBR-green/PI assay (LM: esti-
mate= 0.309, st.err.= 0.056, t-value= 5.483, p < 0.001,
d.f.= 16) (Fig. 3F, G).
Finally, taking advantage of fluorescent transgenes and
birefringence properties in the zebrafish organism, we
investigated the morphology of liver and skeletal muscle,
two of the most affected tissues in Polg-related disease25.
For liver analysis, we measured the fluorescence of liver-
specific transgenic zebrafish at 8 and 16 dpf (Fig. 4A–D).
The statistical analysis did not reveal any significant dif-
ference between 8 dpf polg+/+ and polgsa9574/sa9574 larvae,
while a decreased signal, connected to a reduced (non-
isometric) organ size, was found in mutants at 16 dpf
(Fig. 4E).
To assess for in vivo defects in the amount and/or
organization of myofibrils, we exploited the birefringence
(see figure on previous page)
Fig. 1 polgmorphants characterization and specific signalling pathway alteration. A, B Molecular validation of polg-specific morpholino oligos.
Semi-quantitative RT-PCR from total cDNA of not injected (not inj), mismatched-morpholino (mismMO) injected controls and polg-specific
morphants (MO), at 1 and 2 dpf, detects-specific alteration of polg transcripts. Arrowheads indicate altered cDNA products exclusively in polg
morphant embryos (A). Control actb1 transcripts appear unaltered under all conditions (B). M marker. PCR experiments were performed in triplicate
on cDNA samples derived from N= 30 whole embryos per condition. Quantifications are displayed in the (M) chart. C, D Cardiac dilation in polg
morphants. Frontal views of control (C) and polg morphant (D) embryos at 2 dpf. Note the enlarged atrium in the morphant; a atrium, v ventricle.
Atrial measurements are displayed in the (N) chart. E, F TEM analysis of mitochondria in the skeletal muscle of 2-dpf embryos: normal mitochondrial
morphology in controls (E); fused and swollen mitochondria in morphants (altered areas indicated by black arrowheads (F). G–L Analysis of Hif-
Hypoxia and Wnt signalling pathways under polg deficiency. Bright field (G, I, J) imaging shows a decreased body length, in the absence of overt
dysmorphology, in 1 and 2-dpf morphant embryos; measurements are displayed in the (O) chart. Fluorescence (H, K, L) imaging of Hif-Hypoxia (HRE
Hif-Hypoxia Responsive Elements) and Wnt signalling reporters shows strong activation of the Hif-Hypoxia pathway under polg-deficieny, in both
green (H) and red (K, L) transgenic background. On the contrary, Wnt signalling appears unchanged (compare K with L). Relative intensity (R.I.)
quantifications of the fluorescent signals are displayed in the (P) and (Q) charts. Statistical tests: one-way ANOVA followed by Tukey’s test; ***p <
0.0001; **p < 0.001; n.s. not significant; N= 6 samples per condition, in triplicate.
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Fig. 2 Editing of the zebrafish polg gene. A Zebrafish polg exons are shown as color-coded boxes corresponding to protein domains of the Polg
peptide. Black arrows show the position of the CRISPR/Cas9-targeted site in exon 2 of the polgia302 mutant line, and the missense mutation in exon 22
of the polgsa9574 mutant line. In the polg+/+ (up) vs. polg−/− (down) sequences, the CRISPR/Cas9-targeted site is in italic and the protospacer adjacent
motif (PAM) is underlined. The new stop codons generated in both mutants are indicated with *= TGA, in red. B, C polgia302/ia302 individuals fail to
survive to three weeks (B), while part of polgsa9574/9574 animals can survive to adulthood (C). In the Kaplan–Meier survival curve for polgsa9574, time is
shown in days post-fertilization (dpf); N= 50 individuals per genotype. The Log Rank test was used for statistical analysis; polg+/+ vs. polgsa9574/sa9574:
p < 0.0001. D Body length analysis in wt (polg+/+), heterozygous (polg+/ia302) and homozygous (polgia302/ia302) individuals. The body length of
zebrafish polgia302/ia302 mutants is significantly reduced compared to controls at 15 dpf. Heterozygotes body length is indistinguishable from wt at all
considered stages. N= 8, in triplicate; **p < 0.01. E Body length analysis in wt (polg+/+), heterozygous (polg+/sa9574) and homozygous
(polgsa9574/sa9574) individuals. The body length of zebrafish polgsa9574/sa9574 mutants is significantly reduced compared to control and heterozygous
individuals at all considered stages. N= 8, in triplicate; *p < 0.05; **p < 0.01. F Representative images of a zebrafish polg+/+ control and a polgia302/ia302
mutant at 16 dpf; a polg+/+ control is compared with a polg+/ia302 heterozygote at 90 dpf. G Representative images of a zebrafish polg+/+ control
and a polgsa9574/sa9574 mutant at 16 and 90 dpf.
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properties of zebrafish skeletal muscle. The analysis,
performed in 3 dpf embryos, revealed similar signals in
control and heterozygous embryos (not shown), while
a strong birefringence decrease was detected in
polgsa9574/sa9574 larvae compared to wt (Fig. 4F–J).
In summary, these findings indicate the presence of
significant multiorgan defects in polgsa9574 mutant larvae
and adults, involving liver size, skeletal muscle mass, heart
morphology and gonadal function, the latter character-
ized, in males, by reduced viability of the mutant sperm.
polgsa9574 mutants display alterations in mitochondrial
mass, organization, function and retrograde signalling
The multisystem defects detected in polg mutants cor-
roborate the important role of Polg activity and mito-
chondrial integrity in the maintenance of organ size and
function. Previous research, for instance, has suggested
that sarcopenia correlates with a loss of mitochondria
content1,26. To assess the mitochondrial organization in
the skeletal muscle of polgsa9574 mutants, we took
advantage of a mitochondrial-targeted transgene Tg(Hsa.
Cox8a:MLS-EGFP)ia301 (“mitoEGFP”) allowing the fluor-
escent visualization of these organelles in vivo. With this
tool, we could detect an alteration of organelle distribu-
tion along the fibres and a decrease of mitochondrial mass
(Fig. 4K–O), which was accompanied by a significant
reduction of mtDNA content in homozygous mutants, as
assessed by qPCR (Fig. 4P). In parallel, transmission
electron microscopy analysis could identify a significant
increase of mitochondria with aberrant cristae morphol-
ogy in the skeletal muscle of polgsa9574/sa9574 mutants
(Fig. 4Q–S).
Led by the results obtained with transient KD (Fig. 1),
we double-checked if these mitochondrial phenotypes
Fig. 3 Effects of Polg mutation on heart and gonads of adult zebrafish. A Cardiac EE histology shows a clear reduction of the thickness of the
trabecular network in mutant hearts; a atrium, cm compact myocardium, t trabeculae, v ventricle. B Ovarian EE histology detects oocyte maturation
defects in mutant females; black arrowheads indicate debris of atretic follicles. po primary oocyte, cao cortical-alveolar oocyte, vo vitellogenic oocyte.
C Testicular EE histology detects a reduced amount of spermatozoa (sp) in mutant males. Concentration (D), velocity (E) and viability (F) of ejaculated
sperm. Depicted is mean ± SEM. ***p < 0.001; N= 10, in triplicate. G Illustrative image of fluorescence staining evidencing a higher amount of dead
(red) over alive (green) sperm in polgsa9574/sa9574 males.
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could arise in association with the stimulation of typical
mitochondria-to-nucleus retrograde communications.
When focusing our attention on CREB and Hif-Hypoxia
signalling, we detected a 3–4-fold increase in the activa-
tion of both pathways in polgsa9574/sa9574 mutants (Fig. 5A,
B). Notably, Hif-hypoxia hyper-activation was also con-
firmed in vivo in polgia302/ia302 mutants, using a Hif-
hypoxia-responsive transgene (Fig. 5C–E).
Finally, to verify more directly whether polg mutation
could affect mitochondrial function, we measured the
oxygen consumption rate (OCR) using a Seahorse extra-
cellular flux analyser. The oxidative respiration was ana-
lysed in 4 dpf whole embryos, first under basal conditions,
then under FCCP stimulation and, finally, under Rote-
none/Antimycin A-mediated inhibition, which allows the
evaluation of nonmitochondrial oxygen consumption (Fig.
5F). The G chart in Fig. 5 compares wt and mutant net
mitochondrial respiration. Quantifications of these mea-
surements show a highly significant decrease of basal
OCR in polgsa9574/sa957 homozygotes, compared to con-
trols, confirming the mitochondrial dysfunctionality in
this mutant line.
During oxidative phosphorylation in the mitochon-
drion, molecular oxygen is transformed into highly reac-
tive oxygen species (ROS) in the electron transport chain.
Taking advantage of the MitoSOX indicator for in vivo
visualization of mitochondrial superoxide production, we
observed a decrease of the signal in polgsa9574/sa957mu-
tants compared to controls (Supplementary Fig. 3a–c). In
line with this observation, polg
sa9574/sa957
mutants also showed
decreased expression of ROS-induced genes nqo1 and
txnrd3 (Supplementary Fig. 3D), further corroborating a
reduced mitochondrial activity in mutants.
Polgia302 mutants display alterations in myofibrils,
locomotion, ROS and retrograde signalling
Due to their larval lethality, polgia302/ia302 mutants have
been only preliminarily characterized, within a 2-week
time frame; specifically, reduced birefringence was
detected at 3 dpf in homozygous individuals, compared to
heterozygous and wt siblings, suggesting early myofibril
disorganization (Supplementary Fig. 4A, A’). To further
investigate this aspect, locomotion tests were performed
on all genotypes, at 6 and 15 dpf. Behavioural assays
showed that the genetic ablation of polg does not affect
the normal responses to light stimuli of 6-dpf larvae
(Supplementary Fig. 4B, B’) However, at 15 dpf, both
heterozygous and homozygous larvae display altered
responsiveness to light stimuli, as the total distance swum
by these individuals appeared significantly reduced com-
pared to wt siblings (Supplementary Fig. 4C, C’). These
results demonstrate that polg mutations may affect loco-
motor ability of zebrafish larvae, and that this effect can be
appreciated also under heterozygous condition. Further
characterizations have been performed in polg+/ia302
heterozygotes during adulthood, failing to detect sig-
nificant differences in mtDNA content within selected
organs, such as heart, brain, gonads and skeletal muscle
(Supplementary Fig. 4D). Interestingly, though, hetero-
zygous polg+/ia302 individuals showed increased expres-
sion of Hif-Hypoxia and CREB targets, and reduced
expression of ROS-induced genes, at both cardiac and
brain level (Supplementary Fig. 4E, F), strikingly in line
with observed variations in polg morphants and polgsa9574
mutants, suggesting that this retrograde signalling pattern
could represent a common molecular signature under
Polg dysfunction.
CLO treatment can rescue Polg-related mitochondrial and
cardio-skeletal muscle defects
As the Clofilium tosylate (CLO) compound has been
shown to rescue Polg-related phenotypes in yeast and
nematode8, we tested its effects at the whole vertebrate
animal level, exploiting our zebrafish polg mutants. First,
to determine the optimal working dose, wt individuals
were grown with increasing concentrations of CLO, from
5 dpf (mouth opening stage) up to 12 dpf. The drug was
directly diluted in fish water. Supplementary Fig. 5A
represents the survival chart. Among the tested doses, the
highest non-toxic concentration of CLO was 5 μM, while
higher concentrations resulted in toxic effects. Indeed,
larvae exposed to 10 µM CLO displayed malformations in
(see figure on previous page)
Fig. 4 Effects of Polg mutation on liver, skeletal muscle and mitochondria. A–D Representative Z projections of 3D confocal images of wt and
polgsa9574/sa9574 liver at 8 and 16 dpf. The quantification of liver-specific fluorescence from the lfabp10a:DsRed transgene (E) indicates reduced liver
size in 16 dpf mutants. F–I Reference bright field images (F, G) and light microscopy analysis of muscle birefringence (H, I) in wt and polgsa9574/sa9574
embryos at 3 dpf. The birefringence quantification (see Methods) shows reduced signal in mutants (J). K–N Confocal images of the Tg(Hsa.Cox8a:
MLS-EGFP)ia301 mitochondrial marker (mitoEGFP) in wt (K, M) and polgsa9574/sa9574 (L, N) at 16 dpf. The relative quantification of integrated density (O)
indicates a reduced mitochondrial mass. P The relative quantification of mtDNA copy number, in wt and polg sa9574 mutants, shows a significant
reduction of mtDNA in homozygotes. Data are presented as mean ± SEM and were generated from three different experiments, each containing six
embryos per genotype and treatment condition (*p < 0.05; **p < 0.01; N= 6, in triplicate). Q, R TEM analysis of mitochondria in 16 dpf skeletal muscle
fibres (sm) of wt and polgsa9574/sa9574 detects vesicular cristae with “honeycomb” arrangement inside the mutated mitochondria (indicated by black
arrowheads). S Quantification of aberrant morphologies; ***p < 0.001; N= 8 independent TEM images per condition, in triplicate.
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the pectoral fin, reduced growth, curved body and
microcephaly (Supplementary Fig. 5B–E).
Once the toxicity of CLO was determined, we pro-
ceeded to test the efficacy of this drug in relation to the
mtDNA depletion phenotype. As previously shown (Fig.
4P), in the absence of treatment polgsa9574/sa9574 mutants
displayed a 20–25% reduction of mtDNA, compared to
healthy controls (see also Fig. 6A, A’). Addition of 5 μM
CLO to fish water (from 6 to 11 dpf) induced an increase
of mtDNA copy number in polgsa9574/sa9574 mutants,
reaching a 1.5-fold change compared to the untreated
mutants. Notably, CLO treatment of healthy controls
could also induce a 1.3-fold increase of mtDNA, com-
pared to the reference level (Fig. 6A, A’).
To obtain a stronger reduction of mtDNA in controls
and polgsa9574/sa957 mutants, we performed an ethidium
bromide (EtBr) treatment. EtBr is an intercalating dye that
preferentially incorporates into circular DNA, halting
replication and transcription. Treatment with 15 µg/mL
EtBr for 5 days can significantly reduce the relative
quantity of mtDNA in zebrafish larvae, compared to
untreated controls6. In our setup, embryos were
Fig. 5 Altered signalling and mitochondrial dysfunction in polg mutants. A The CREB signalling-targeted gene fosab is upregulated in 4 dpf
polgsa9574/sa9574 mutants, compared to controls. B The Hif-Hypoxia signalling-targeted gene hbbe3 is upregulated in 4 dpf polgsa9574/sa95 mutants,
compared to controls. C–E Hif-Hypoxia signalling increases also in 6-dpf polgia302/ia302 mutants, as shown by the Hif-Hypoxia-responsive transgene
HRE:mCherry. E Chart reporting the HRE fluorescence relative intensity (R.I.). F Diagram depicting the oxygen consumption rate (OCR) profile
throughout Seahorse assay in 4 dpf wt and polgsa9574/sa9574 embryos under basal conditions, FCCP (p-triFluoromethoxyCarbonylCyanide
Phenylhydrazone)-induced maximal respiratory capacity stimulation and ROT/AA (Rotenone/Antimycin A)-mediated inhibition. Three independent
experiments were performed (N= 20). G Quantification of basal respiration in wt and polgsa9574/sa9574 mutants (N= 20, in triplicate).
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pre-treated with EtBr for the first 5 days of development,
after which they were rinsed and allowed to grow in the
presence or absence of CLO for 6 days. At 11 dpf, in the
absence of CLO, polgsa9574/sa9574 animals exposed to EtBr
had significantly lower mtDNA values (58.2% reduction)
than polg+/+ treated fish, suggesting delayed or decreased
mtDNA repopulation rates for the mutant Polg compared
to the wt enzyme. At 11 dpf, all CLO-treated larvae had
higher amounts of mtDNA than untreated individuals of
the same genotype, with an increase by 1.6-fold in wt and
2.3-fold in mutants, compared to untreated controls (Fig.
6B, B’). This increase of mtDNA due to CLO treatment is
significantly higher in animals pre-treated with EtBr,
compared to those not exposed to EtBr, supporting the
CLO treatment as a highly effective in vivo treatment for
the restoration of mtDNA depletion in a Polg-deficient
vertebrate system.
An additional Polg-related phenotype, associated to
mtDNA depletion, is represented by the reduced amount
of mitochondrial-encoded proteins, including Complex I
components, which lead to typical Complex I deficiencies
observed in Polg patients27. We have verified Complex I
activity in mutants, detecting a 43% decrease of its effi-
ciency in the skeletal muscle of adult mutants, compared
to wt tissue (Fig. 6C). Consequently, we decided to
investigate whether Complex I activity could be rescued
by CLO treatment, in this case performed at the adult
stage. The administration of CLO for 6 days on 6-mpf
individuals could induce a 2.4-fold increase of Complex I
performance in treated mutants, compared to untreated
ones (Fig. 6C), supporting CLO as an effective drug for
the rescue of Complex I activity under Polg deficiency,
with proved efficacy also during adulthood. Given the net
effect of CLO on mitochondrial function, we checked if
this drug could affect the mitochondria-to-nucleus ret-
rograde signalling, detecting a striking reduction of both
Hif-Hypoxia- and CREB-mediated response (Fig. 6D–F).
Finally, focusing on polgsa9574 skeletal muscle, we found
that CLO treatment could successfully rescue the myofi-
bril organization, analysed through birefringence (Fig. 6G,
G’), and the mitochondrial mass, visualized by
mitochondrial-directed EGFP (Fig. 6H, H’). Notably, also
cardiac phenotypes such as atrial enlargement and
tachycardia, induced by morpholino-mediated Polg defi-
ciency, could be restored to normal values (Fig. 6I, J) after
a 2-day treatment with CLO, supporting a multiorgan
efficacy of this drug.
Discussion
The current lack of satisfactory POLG models and of an
effective therapy for POLG-related disorders is the main
aspect that inspired our work. The use of different
approaches to model POLG dysfunction in zebrafish
(antisense oligomers, point mutants and deletion
mutants) represents a powerful strategy that allowed us to
compare the induced phenotypes under transient loss-of
function, as well as under stable hypomorphic and severe
gene disruption. Specifically, in this study, the robust
comparison among different zebrafish POLG models took
advantage of multiple techniques, including the polg
downregulation by morpholino, and the use of two stably
mutated polg alleles: an adult-viable ENU-induced point
mutation (line polgsa9574) and a larval-lethal CRISPR/
Cas9-induced microdeletion (line polgia302).
Interestingly, under different conditions, we could note
the exhibition of common phenotypes, including devel-
opmental delay, reduced body size, cardiac defects and
mitochondrial dysmorphology. Of note, both Polg
downregulation and stable mutation can activate
mitochondria-to-nucleus retrograde signalling such as
Hif-Hypoxia and CREB pathways, both representing
adaptive responses that communicate to the nucleus the
(see figure on previous page)
Fig. 6 The CLO compound can rescue mitochondrial and cardio-skeletal defects in polg mutants. A, B Comparison of relative abundances of
the mitochondrial nd1 gene in the presence of CLO, in wt and polgsa9574/sa9574 zebrafish, untreated (A) or treated (B) with Ethidium Bromide (EtBr).
polg+/+ zebrafish recover from EtBr-induced mtDNA depletion while polgsa9574/sa9574 mutants remain depleted of mtDNA. (A’, B’) Data in A’ and
B’ charts were generated from three different experiments, each containing a pool of six embryos per genotype and treatment condition (N= 6, in
triplicate). C Complex I activity in polgsa9574/sa9574 adult muscle tissue is significantly lowered, and can be rescued after CLO treatment. Data were
generated from three different experiments, each containing a pool of four samples per genotype and treatment condition (N= 4, in triplicate).
D–F Retrograde signalling decrease after CLO treatment, based on the expression of the Hif-Hypoxia targets hbbe3 and pfkfb3 (D, E), and the CREB-
responsive gene fosab (F); N= 5. G Muscle birefringence, reduced in polgsa9574/sa9574 mutants compared to siblings, can be rescued by CLO
treatment. G’ Relative intensity (R.I.) quantifications of experiments shown in G; N= 10 per genotype. H The mitochondrial mass, analysed at 6 dpf by
mitochondria-targeted EGFP Tg(Hsa.Cox8a:MLS-EGFP) in the skeletal muscle of all polgsa9574 genotypes, is reduced in homozygotes (compare C with
A, B), and can be rescued by CLO treatment (D–F). H’ Relative intensity (R.I.) quantifications of experiments shown in H; N= 9 per genotype. I The
atrial diameter (dashed white lines), enlarged in 2-dpf polg morphants (C) compared to not injected (A) and control-injected (B) embryos, can be
restored to normal values after CLO treatment (D–F). Cardiac chambers are visualized by Tg(tg:EGFP,myl7:EGFP)ia300. I’ Quantifications of experiments
shown in I; the atrial diameter is expressed in arbitrary units (A.U.); N= 6 per condition. J The heart rate, increased in polg morphants (MO) compared
to controls (N.i.; mMO), can be restored to normal values after CLO treatment; N= 10 per condition; Bpm beats per minute. All charts in Fig. 6 display
data as mean ± SEM; n.s. not significant; *p < 0.05; **p < 0.01; ***p < 0.001.
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status of mitochondrial metabolism and genetic instabil-
ity28–30. Specifically, CREB signalling can sense mito-
chondrial dysfunction that leads to increased intracellular
calcium, while Hif-Hypoxia signalling, mediated by
hypoxia-inducible factors (Hif), is activated by low O2
tensions but also under mitochondrial dysfunction, and/
or accumulation of intracellular metabolites31, leading to
a pseudohypoxia state32. The reduced growth, observed in
mutants, may be indeed included among the Hif-Hypoxia
signalling-induced adaptations to energy depletion33.
These aspects are of scientific and medical relevance, as
these signalling cascades and their transducers, shown
here to be hyperactivated at embryonic stages, may
represent early diagnostic signs and candidate processes
for molecularly targeted therapies in POLG disorders.
Our set of multiple POLG models has been also
exploited to analyse a series of multiorgan defects that
characterize the complex spectrum of POLG disorders.
Most notably, the transient downregulation of Polg in
zebrafish can already induce at embryonic stages a
peculiar enlargement of the cardiac atrium, associated
with increased heart rate. Taking advantage of adult-
viable polgsa9574 mutants, dilated heart and reduction of
the trabecular network could be observed and confirmed
at advanced developmental stages; interestingly, dilated
cardiomyopathy has been included among the POLG-
associated signs34. Moreover, as liver and skeletal muscle
represent two of the most affected tissues in POLG
patients, we focused our attention on these anatomical
districts, detecting nonisometric reduction of the hepatic
tissue, and skeletal muscle defects including altered
birefringence properties of the muscle fibres, decrease of
the mitochondrial mass and aberrant mitochondrial
cristae. The histopathological phenotypes at the cardiac,
hepatic and skeletal muscle level occur in parallel with a
net decrease of polg mRNA levels, as shown by our
expressional analysis in these tissues, suggesting potential
mRNA decay or retrograde signalling mechanisms invol-
ving the polg locus. As the severity of the mtDNA
depletion is known to be tissue-specific and in correlation
with respiration6, this could explain our histopathological
findings, supporting altogether the zebrafish organism as
a suitable system to faithful model multiorgan defects in
POLG-related diseases.
In addition, considering that POLG mutations may
underlie male infertility and premature menopause in
human patients, and that C. elegans POLG models show
sterility and gonadal dysgenesis8, we included in our
investigation the reproductive system of zebrafish polg
mutants. The histological analysis of both female and
male gonads highlighted a set of defects, ranging from
altered maturation of ovarian follicles to testicular hypo-
plasia and reduced sperm viability. Interestingly, this
suggests an extremely conserved role for Polg activity in
gonadal development and function, from both inverte-
brate and non-mammalian vertebrate models, up to
human patients.
Concerning the mitochondrial functionality in zebrafish
polg mutants, this was ascertained through both indirect
and direct assays, measuring mitochondrial mass, mor-
phology and mtDNA content, as well as superoxide pro-
duction, ROS signalling activation, oxygen consumption
and Complex I activity. All these parameters, without any
exception, converged towards the identification of a sig-
nificant decrease of mitochondrial function, the leading
pathogenetic mechanism in POLG-related disorders.
Indeed, and not surprisingly, mutations in a fundamental
gene involved in mtDNA maintenance, such as POLG, are
expected to lead to a progressive depletion of mtDNA and
thus of mtDNA-encoded proteins for oxidative phos-
phorylation (OXPHOS) and electron transport chain,
causing Complex I deficiencies in POLG patients as well
as in model systems35.
Being these dysfunctions the molecular aspects most
desirably targetable by a therapeutic approach, we took
advantage of preliminary evidences for an effective activity
of the drug CLO in rescuing mtDNA depletion in yeast-,
worm- and human fibroblast-based models for POLG
disease8. In our study, after systemic treatment of mutant
zebrafish with CLO, we could define a whole-body non-
toxic dosage able to successfully rescue mtDNA quantity
to normal levels, even when the mutant phenotype was
strongly exacerbated by Ethidium Bromide treatment.
Interestingly, this CLO activity proved to be so effective as
to induce significant effects also in normal individuals,
where the amount of mtDNA could undergo a 25%
increase of the basal level. Moreover, the efficacy of CLO
was further demonstrated by its ability to rescue Complex
I activity in zebrafish polg mutants; this effect was so
pronounced as to induce at least a 33% increase in both
normal and mutated individuals. In parallel, a drastic
decrease of Polg-induced retrograde signalling was
observed in mutant larvae after CLO treatment. Finally,
the drug proved to be also effective in restoring Polg-
related cardio-skeletal defects, assessed in terms of ske-
letal muscle birefringence and mitochondrial mass, car-
diac frequency and atrium size. To our knowledge, these
are the first evidences of CLO-induced mitochondrial and
cardio-skeletal rescue successfully obtained at the whole
vertebrate level; overall, these results appear very
encouraging in view of a systemic therapy in human
POLG patients.
The CLO molecule is an antiarrhythmic agent belong-
ing to Class III as it acts as a Potassium (K+) channel
blocker. A still unknown target of CLO, related to
mtDNA maintenance, may exist, with high conservation
in yeast, invertebrates and vertebrates, since CLO treat-
ment leads to similar effects in different in vivo models.
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In this regard, the zebrafish organism can represent an
excellent system where to test candidate mechanisms for
CLO activity, ranging from the stabilization of the Polg
enzyme to the control of the intracellular ion homeostasis.
Among other known Class III antiarrhythmic agents,
ibutilide and dofetilide share common chemical structure
with CLO8. As these drugs proved to be effective in the
treatment of POLG worm models, although not at levels
comparable with CLO8, it would be interesting to test
them in a vertebrate setup. Future directions could also
point to the analysis of CLO efficacy in rescuing tissue-
specific phenotypes, such as hepatic, locomotor or gona-
dal dysfunction. For instance, since CLO treatment in
worm models has been shown to induce an increase of
laid eggs8, and considering the crucial role of mitochon-
dria in germ-cell selection and gametic function36, it
would be tempting to verify if CLO can at least partially
rescue ovary dysmorphology and sperm viability in zeb-
rafish mutants. Finally, with these zebrafish polg lines,
now validated and stably maintained, more long-term
experiments could be setup, including regeneration assays
and multigeneration follow-ups, to investigate the aging
process under POLG dysfunction.
In conclusion, we believe that this set of zebrafish-based
POLG mutants, with either strong or mild phenotypes,
may represent precious tools in an experimental pipeline
that, taking advantage of unicellular (yeast), invertebrate
(worm) and vertebrate (zebrafish) models, can system-
atically exploit these systems at the best of their potential
for comparative phenotyping and large-scale screens for
new POLG-targeted therapies.
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